Medication info
Barostat 40 mg Tablet (Atorvastatin Calcium Trihydrate)

Barostat 40 mg Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201906327 · Approved 2019.09.05 · Insurance code 644004340

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who uses it
Adults
Adult dosage
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular invasive procedures
  • stable chronic angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hyperlipidemia
View approved original text

This medication helps reduce the risk of myocardial infarction, stroke, and vascular invasive procedures in adults with various risk factors for cardiovascular disease and in patients with diabetes. Additionally, it reduces the risk of hospitalization due to myocardial infarction, stroke, angina, and congestive heart failure in patients with heart disease. Furthermore, it is used to reduce total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol in patients with hyperlipidemia, thereby improving blood lipid levels. This drug is also effectively used as an adjunct in various types of dyslipidemia that do not respond well to dietary changes. Thus, this medication is used beneficially to maintain cardiovascular health and manage hyperlipidemia.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.

Precautions

This medication can affect the muscles; therefore, if there are severe muscle pain or weakness, or if muscle enzyme levels significantly increase, discontinue use immediately and consult a doctor. This drug should not be used in individuals with certain liver diseases or those with significantly elevated liver enzyme levels, or in those with muscle disorders. This medication is not given to pregnant women, those who may become pregnant, nursing mothers, or children under 10 years of age. Since this medication can affect liver function, regular liver function tests should be performed before and during treatment, and if symptoms of hepatitis or jaundice occur, the doctor should be notified immediately. Patients who consume a lot of alcohol or have a history of liver disease should use this medication cautiously. Increased plasma concentrations of this drug can heighten the risk of muscle damage; therefore, careful consideration is needed when taken with certain antibiotics, antifungals, or antivirals. It is advisable to avoid grapefruit juice during treatment, and to consult a doctor or pharmacist when taking this drug along with other medications. If symptoms such as muscle pain, weakness, or fever occur during treatment, notify a doctor immediately for evaluation. Elderly patients or those with reduced kidney function are at a higher risk of muscle damage, so careful observation is required during use. Women of childbearing age should use appropriate contraceptive methods while taking this drug, and if pregnancy is confirmed, the medication should be discontinued immediately. This medication is not recommended for nursing women, and breastfeeding should be discontinued during treatment. There is no specific antidote for overdose; therefore, treatment is symptomatic, and liver function and muscle enzyme tests should be conducted. This medication should be kept out of reach of children and stored in its original container to prevent deterioration.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 186 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • oropharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • sensory disturbance
  • decreased sensation
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • dark stools
  • gingival bleeding
  • hypertonia
  • bronchitis
  • rhinitis
  • pneumonia
  • shortness of breath
  • asthma
  • sensory disturbances
  • dizziness
  • photosensitivity
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • increased tension
  • myositis
  • muscle diseases
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgent urination
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypoglycemia
  • increased appetite
  • vasculoneurogenic edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • eye hemorrhage
  • auditory loss
  • glaucoma
  • taste alteration
  • loss of taste
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • sleep disturbances
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • cognitive impairment
  • muscle weakness
  • ocular muscle weakness
  • increased AST
  • abnormal liver function
  • jaundice
  • fulminant hepatitis
  • hepatitis
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • erythema multiforme

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air or moisture from entering. It is also important to keep it at room temperature, between 1 to 30 degrees Celsius, avoiding extremely hot or cold places.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.